Maraiki F - Search Results

1

Real-World Outcome and Prognostic Factors of Pazopanib in Advanced Soft Tissue Sarcoma.

Alshamsan B, Badran A, Alshibany A, Maraiki F, Elshenawy MA, Elhassan T, Atallah JP. Alshamsan B, et al. Among authors: maraiki f. Cancer Manag Res. 2021 Aug 29;13:6755-6766. doi: 10.2147/CMAR.S323499. eCollection 2021. Cancer Manag Res. 2021. PMID: 34512015 Free PMC article.

2

Thromboembolic Events Burden in Patients With Solid Tumors and Their Predisposing Factors.

Bazarbashi S, Alkhaldi T, Aseafan M, Melaibari M, Almuhisen S, Alharbi S, Alghabban A, Aljumaa J, Eldali A, Maraiki F, Owaidah T, Alzahrani H. Bazarbashi S, et al. Among authors: maraiki f. Cureus. 2022 Mar 29;14(3):e23624. doi: 10.7759/cureus.23624. eCollection 2022 Mar. Cureus. 2022. PMID: 35386484 Free PMC article.

3

Utilization and cost of electronic resources in adult cancer center.

Maraiki F, Kelly S, Ahmed M, Balhareth S, Elhasan T, Aljurf M, Bazarbashi S. Maraiki F, et al. BMC Res Notes. 2018 Jul 28;11(1):516. doi: 10.1186/s13104-018-3637-6. BMC Res Notes. 2018. PMID: 30055654 Free PMC article.

4

Methodological Approaches to Cost-Effectiveness Analysis in Saudi Arabia: What Can We Learn? A Systematic Review.

Maraiki F, Bazarbashi S, Scuffham P, Tuffaha H. Maraiki F, et al. MDM Policy Pract. 2022 Mar 21;7(1):23814683221086869. doi: 10.1177/23814683221086869. eCollection 2022 Jan-Jun. MDM Policy Pract. 2022. PMID: 35647291 Free PMC article. Review.

5

Empirical Monetary Valuation of a Quality-Adjusted Life-Year in the Kingdom of Saudi Arabia: A Willingness-to-Pay Analysis.

Bazarbashi S, De Vol EB, Maraiki F, Al-Jedai A, Ali AA, Alhammad AM, Aljuffali IA, Iskedjian M. Bazarbashi S, et al. Among authors: maraiki f. Pharmacoecon Open. 2020 Dec;4(4):625-633. doi: 10.1007/s41669-020-00211-0. Pharmacoecon Open. 2020. PMID: 32291726 Free PMC article.

6

Eliminating the use of intravenous glass bottles using a FOCUS-PDCA model and providing a practical stability reference guide.

Maraiki F, Farooq F, Ahmed M. Maraiki F, et al. Int J Pharm Pract. 2016 Aug;24(4):271-82. doi: 10.1111/ijpp.12245. Epub 2016 Feb 9. Int J Pharm Pract. 2016. PMID: 26857236

7

International HTA Experience with Targeted Therapy Approvals for Lung Cancer.

Maraiki F, Byrnes J, Tuffaha H, Hinder M. Maraiki F, et al. Pharmacoecon Open. 2019 Mar;3(1):103-117. doi: 10.1007/s41669-018-0088-x. Pharmacoecon Open. 2019. PMID: 30076583 Free PMC article.

8

Carotid and brachiocephalic arteries stenosis with long term use of sorafenib.

Maraiki F, Aljubran A. Maraiki F, et al. Hematol Oncol Stem Cell Ther. 2014 Mar;7(1):53-5. doi: 10.1016/j.hemonc.2013.06.005. Epub 2013 Jul 24. Hematol Oncol Stem Cell Ther. 2014. PMID: 23892125 Free article.

9

Combining Sunitinib and Bevacizumab for the Management of Advanced Renal Cell Carcinoma: A Phase I/II Trial.

Bazarbashi S, Alzahrani A, Aljubran A, Elshenawy M, Gad AM, Maraiki F, Alzannan N, Elhassan T, Badran A. Bazarbashi S, et al. Among authors: maraiki f. Oncologist. 2023 May 8;28(5):e254-e262. doi: 10.1093/oncolo/oyac261. Oncologist. 2023. PMID: 36648325 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters